These Convalescent Plasma Therapy Players Got a Nice Boost.
$ADMA Biologics(ADMA.US$ jumped by a healthy 68%, $iBio Inc(IBIO.US$ rose by a handsome 28%, and $Kamada(KMDA.US$ perked up as much as 24% in early morning action today as President announced that the Food and Drug Administration issued an emergency use authorization (EUA) for convalescent plasma therapy as a treatment for hospitalized COVID-19 patients on last Sunday.
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment